Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,174 | 46,134 | 13,738 | 3,935 | 18,994 |
| Marketable Securities | 7,080 | 0 | N/A | N/A | 1 |
| Receivables | N/A | 1,861 | 1,054 | 1,011 | 5,872 |
| Inventories | N/A | N/A | 1,113 | 648 | 21,023 |
| Income taxes - deferred | N/A | 1,270 | N/A | N/A | N/A |
| Other current assets | 10,027 | 1,562 | 803 | 33,017 | 994 |
| TOTAL | $36,282 | $50,827 | $16,707 | $38,610 | $46,883 |
| Non-Current Assets | |||||
| PPE Net | 15,961 | 12,844 | 11,153 | 11,616 | 36,998 |
| Intangibles | 72,770 | 24,993 | 25,599 | 26,204 | 56,276 |
| Other Non-Current Assets | 1,264 | 1,152 | 947 | 78,898 | 2,867 |
| TOTAL | $89,994 | $38,989 | $37,699 | $116,717 | $96,142 |
| Total Assets | $126,275 | $89,816 | $54,406 | $155,328 | $143,025 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,110 | N/A | N/A | N/A | 3,034 |
| Accounts payable and accrued liabilities | 5,661 | 3,568 | 5,994 | 5,922 | 14,287 |
| Accrued Expenses | 4,323 | 4,018 | 2,285 | 1,090 | 2,772 |
| Other current liabilities | 4,334 | 1,840 | 1,468 | 1,121 | 1,708 |
| TOTAL | $16,245 | $9,807 | $9,949 | $36,447 | $32,845 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,716 | N/A | 172 | N/A | N/A |
| Other Non-Current Liabilities | 19,658 | 14,108 | 20,466 | 44,422 | 13,779 |
| TOTAL | $51,957 | $17,983 | $11,637 | $38,749 | $23,693 |
| Total Liabilities | $68,202 | $27,790 | $21,586 | $75,195 | $56,537 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 257 | 191 | 112 | 76 | 52 |
| Common Shares | 37 | 27 | 16 | 109 | 64 |
| Retained earnings | -291,247 | -236,374 | -197,392 | -143,095 | -95,321 |
| Other shareholders' equity | -145 | -222 | -23 | 22,259 | 40,607 |
| TOTAL | $58,074 | $62,026 | $32,820 | $80,133 | $86,488 |
| Total Liabilities And Equity | $126,275 | $89,816 | $54,406 | $155,328 | $143,025 |